[Possible adverse effects of phenytoin given transplacentally on the fetal growth. III. Effects of phenytoin on postnatal brain development].
Tanaka
K
K
Naruto
T
T
Yamamoto
H
H
Nishizawa
K
K
Tachiiri
T
T
Okumura
K
K
Shimada
M
M
D063309:2',3'-Cyclic Nucleotide 3'-Phosphodiesterase; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development*; D005260:Female; D008431:Maternal-Fetal Exchange; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D010672:Phenytoin / Q000009:adverse effects* / Q000493:pharmacokinetics; D010727:Phosphoric Diester Hydrolases; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D012018:Reflex / Q000187:drug effects
D010672:Phenytoin; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases; D010727:Phosphoric Diester Hydrolases; D063309:2',3'-Cyclic Nucleotide 3'-Phosphodiesterase; C571338:Cnp protein, mouse